cp wire

CP Wire Articles

Microbiome Report for the week ending 7-29-18


Finch Therapeutics Expands Microbiome IP Portfolio with Six... read more

Wed, 08/1/18 - 11:48 pm
ReViral Completes $55 Million Series B Round to Advance RSV Treatment
  • RSV causes 30 million infections and 200,000 deaths worldwide in children under 5 alone
  • The company's lead candidate, RV521, is currently in Ph II trials


... read more

Wed, 08/1/18 - 10:35 am
Northern Biologics Adds Industry Veterans to Management Team

Northern Biologics Inc. announced on 8/1/18 the appointment of Enda Moran, Ph.D., MBA, as vice president and head of Chemistry Manufacturing and Controls (CMC), and Frédéric Sweeney, Ph.D., as... read more

Wed, 08/1/18 - 10:12 am
Clover Initiates Ph I Study of Enbrel Biosimilar in China
  • Currently available Enbrel biosimilars in China were not compared to the originator
  • Current biosimilars only available in lyophilized powder
  • SCB-808 will be available in pre... read more
Wed, 08/1/18 - 09:43 am
Innovate to Study Larazotide's Effect on Microbiome of Children with EED
  • Larazotide has received Fast Track designation from the FDA for celiac disease.
  • Innovate is preparing to enter Ph III registration clinical trials for celiac disease later in 2018... read more
Tue, 07/31/18 - 10:02 am

Pages